8. Microbial metabolic engineering and CRISPR; applications and future prospective

Main Article Content

Taimoor Akhtar, Muhammad Awais, Sahar Sadaqat, Hafiza Noor Afshan Tauqir Malik, Muneeb Riaz, Allah Bakhsh Abdul Qayyum Rao

Abstract

Traditional metabolic engineering alters cell metabolism by modifying pathway enzyme(s) or regulatory protein(s), enhancing the productivity and yield of an industrial fermentation product, or creating novel biochemical substances. As a result, metabolic engineering is now being utilized to produce amino acids, biofuels, medicines, bioplastics, platform chemicals, silk proteins, and other materials. The discovery of bacterial adaptive immune systems based on genomic Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs), the system’s memory, and CRISPR-associated (Cas) proteins was a watershed moment in molecular microbiology. The advancements in CRISPR-Cas-based bacterial genome engineering provide a better understanding of metabolism on a system level and allow for faster strain engineering, both of which are critical for the creation of a bio-based economy based on microbial cell factories. Some microbes like Escherichia coli, streptococcus, closteridium, corynebacteria, and Baccilus are described in this review, which can be engineered in a desired manner to attain productive benefits. These amazing, engineered entities have a biological and mechanistic basis, and their manufactured variants are transforming basic and clinical research.


Keywords: Bacteria; CRISPR-Cas; Genetic engineering; Microbiology; Metabolism; Productivity


http://dx.doi.org/10.19045/bspab.2023.120047

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.